Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS NEW
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-200K
-
Total reported value, excl. options
-
$0
-
Value change
-
-$3.37M
-
Number of sells
-
-3
Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q4 2021
3 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q4 2021.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (0 shares), STATE STREET CORP (0 shares), ACT CAPITAL MANAGEMENT, LLC (0 shares), INVESTMENT MANAGEMENT OF VIRGINIA LLC (616K shares), Roumell Asset Management, LLC (496K shares), VILLERE ST DENIS J & CO LLC (257K shares), ARK Investment Management LLC (165K shares), BROWN ADVISORY INC (61.4K shares), BENJAMIN F. EDWARDS & COMPANY, INC. (58.7K shares), and Zurcher Kantonalbank (Zurich Cantonalbank) (24.6K shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.